NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 156 filers reported holding NEVRO CORP in Q2 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PDT Partners, LLC | 14,659 | $372,632 | 0.05% |
| ALGERT GLOBAL LLC | 43,597 | $1,108 | 0.05% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 355,263 | $9,030,785 | 0.04% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 267,641 | $6,803,434 | 0.04% |
| Versor Investments LP | 8,967 | $227,941 | 0.04% |
| BALYASNY ASSET MANAGEMENT L.P. | 645,195 | $16,400,857 | 0.04% |
| WINTON GROUP Ltd | 16,559 | $420,930 | 0.04% |
| TWO SIGMA ADVISERS, LP | 547,000 | $13,904,740 | 0.04% |
| TWO SIGMA INVESTMENTS, LP | 551,365 | $14,015,698 | 0.04% |
| Dorsey & Whitney Trust CO LLC | 16,374 | $416,227 | 0.03% |
| Jasper Ridge Partners, L.P. | 26,016 | $661,327 | 0.03% |
| TUDOR INVESTMENT CORP ET AL | 96,772 | $2,459,944 | 0.03% |
| D. E. Shaw & Co., Inc. | 1,070,979 | $27,224,286 | 0.03% |
| EXCHANGE TRADED CONCEPTS, LLC | 42,865 | $1,089,628 | 0.03% |
| DUALITY ADVISERS, LP | 8,456 | $214,952 | 0.03% |
| Jump Financial, LLC | 25,900 | $658,378 | 0.02% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 9,263 | $235,465 | 0.02% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 12,625 | $320,928 | 0.02% |
| CAPITAL FUND MANAGEMENT S.A. | 160,222 | $4,072,843 | 0.02% |
| Leucadia National | 71,000 | $1,804,820 | 0.02% |
External links
This page lists NEVRO CORP's shareholders in Q2 2023. To view NEVRO CORP's shareholder history, click here.